198 related articles for article (PubMed ID: 3117952)
21. [Disseminated intravascular coagulation induced by endotoxin in rabbits: effect of treatment with t-PA and urokinase].
Paloma MJ; Páramo JA; Rifón J; Rocha E
Sangre (Barc); 1992 Dec; 37(6):435-8. PubMed ID: 1293794
[TBL] [Abstract][Full Text] [Related]
22. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
23. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.
Vervloet MG; Thijs LG; Hack CE
Semin Thromb Hemost; 1998; 24(1):33-44. PubMed ID: 9515778
[TBL] [Abstract][Full Text] [Related]
24. Hemostatic alterations associated with supraceliac aortic cross-clamping.
Anagnostopoulos PV; Shepard AD; Pipinos II; Raman SB; Chaudhry PA; Mishima T; Morita H; Suzuki G
J Vasc Surg; 2002 Jan; 35(1):100-8. PubMed ID: 11802139
[TBL] [Abstract][Full Text] [Related]
25. The pathogenesis and management of disseminated intravascular coagulation.
Saba HI; Morelli GA
Clin Adv Hematol Oncol; 2006 Dec; 4(12):919-26. PubMed ID: 17235277
[TBL] [Abstract][Full Text] [Related]
26. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit.
Okabayashi K; Wada H; Ohta S; Shiku H; Nobori T; Maruyama K
Am J Hematol; 2004 Jul; 76(3):225-9. PubMed ID: 15224356
[TBL] [Abstract][Full Text] [Related]
27. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
[TBL] [Abstract][Full Text] [Related]
28. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality.
Paloma MJ; Páramo JA; Rocha E
Thromb Haemost; 1995 Dec; 74(6):1578-82. PubMed ID: 8772240
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
30. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
[TBL] [Abstract][Full Text] [Related]
31. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
[TBL] [Abstract][Full Text] [Related]
32. [Qualitative analysis of tissue plasminogen activator in plasma obtained from various liver diseases by gel filtration and affinity chromatography].
Takatori M; Kamogawa A; Iwabuchi S; Moriyama N; Mizuguchi A; Sugai J
Rinsho Byori; 1990 Jan; 38(1):71-5. PubMed ID: 2106595
[TBL] [Abstract][Full Text] [Related]
33. Disseminated intravascular coagulation: What's new?
Levi M
Crit Care Clin; 2005 Jul; 21(3):449-67. PubMed ID: 15992667
[TBL] [Abstract][Full Text] [Related]
34. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
[TBL] [Abstract][Full Text] [Related]
35. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.
Gando S; Kameue T; Nanzaki S; Nakanishi Y
Thromb Haemost; 1996 Feb; 75(2):224-8. PubMed ID: 8815564
[TBL] [Abstract][Full Text] [Related]
36. Sex differences in the determinants of fibrinolytic activity.
MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ
Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046
[TBL] [Abstract][Full Text] [Related]
37. Prospective double-arm study of fibrinolysis in surgical patients.
Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
[TBL] [Abstract][Full Text] [Related]
38. Clinical aspects of DIC--disseminated intravascular coagulation.
Matsuda T
Pol J Pharmacol; 1996; 48(1):73-5. PubMed ID: 9112631
[TBL] [Abstract][Full Text] [Related]
39. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1991 Mar; 36(3):176-83. PubMed ID: 1899963
[TBL] [Abstract][Full Text] [Related]
40. Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis.
Pizzo SV; Fuchs HE; Doman KA; Petruska DB; Berger H
Arch Intern Med; 1986 Jan; 146(1):188-91. PubMed ID: 2935105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
